1 | hoc | 2,451 |
2 | partum | 272 |
3 | mortem | 61 |
4 | hepatitic | 14 |
5 | squares-discriminant | 13 |
6 | stereophotogrammetric | 7 |
7 | squares-discriminate | 6 |
8 | coitum | 4 |
9 | cell-sorting | 3 |
10 | fev1-pre | 3 |
11 | fev1/pre | 3 |
12 | lipocryolyisis | 3 |
13 | lyric | 3 |
14 | multi-array | 3 |
15 | revised-consort | 3 |
16 | segregant | 3 |
17 | square-discriminant | 3 |
18 | 1-only | 2 |
19 | 45/post | 2 |
20 | cibum | 2 |
21 | multichip | 2 |
22 | natum | 2 |
23 | splicing-point | 2 |
24 | squares-discrimination | 2 |
25 | .onset | 1 |
26 | 0.06-μg/l | 1 |
27 | 14,15 | 1 |
28 | 148.1±34.5 | 1 |
29 | 237.21 | 1 |
30 | 24.7±8.8 | 1 |
31 | 3-week-therapy | 1 |
32 | 45.1±24.9 | 1 |
33 | 466.9 | 1 |
34 | 48.1±8.9 | 1 |
35 | 521.6±83.5 | 1 |
36 | 7,670 | 1 |
37 | abcg2-mediated | 1 |
38 | adenoidectomy/tonsillectomy | 1 |
39 | alcohol-negative | 1 |
40 | analysis-biometric | 1 |
41 | cfa-treatment | 1 |
42 | deswelling | 1 |
43 | development.statistical | 1 |
44 | discharge.this | 1 |
45 | distribution.cost-effectiveness | 1 |
46 | fenestram | 1 |
47 | glucose-load | 1 |
48 | histolyticum/perfringens | 1 |
49 | hoc-developed | 1 |
50 | holotomographic | 1 |
51 | indepen- | 1 |
52 | index-interview | 1 |
53 | injectionem | 1 |
54 | interventions.subgroup | 1 |
55 | interventioti | 1 |
56 | laparatomies | 1 |
57 | latent-subgroup | 1 |
58 | llin-distribution | 1 |
59 | morten | 1 |
60 | natally | 1 |
61 | one-variable-at-a-time | 1 |
62 | op. | 1 |
63 | pci-bleeding | 1 |
64 | polt | 1 |
65 | rates.statistical | 1 |
66 | remission-therapy | 1 |
67 | stroke-onset | 1 |
68 | surrogation | 1 |
69 | third-dose | 1 |
70 | transfusionnal | 1 |
71 | transplant.in | 1 |
72 | treatment-by-tiredness | 1 |
73 | volume-strain | 1 |
1 | .onset | 1 |
2 | 0.06-μg/l | 1 |
3 | 1-only | 2 |
4 | 14,15 | 1 |
5 | 148.1±34.5 | 1 |
6 | 237.21 | 1 |
7 | 24.7±8.8 | 1 |
8 | 3-week-therapy | 1 |
9 | 45.1±24.9 | 1 |
10 | 45/post | 2 |
11 | 466.9 | 1 |
12 | 48.1±8.9 | 1 |
13 | 521.6±83.5 | 1 |
14 | 7,670 | 1 |
15 | abcg2-mediated | 1 |
16 | adenoidectomy/tonsillectomy | 1 |
17 | alcohol-negative | 1 |
18 | analysis-biometric | 1 |
19 | cell-sorting | 3 |
20 | cfa-treatment | 1 |
21 | cibum | 2 |
22 | coitum | 4 |
23 | deswelling | 1 |
24 | development.statistical | 1 |
25 | discharge.this | 1 |
26 | distribution.cost-effectiveness | 1 |
27 | fenestram | 1 |
28 | fev1-pre | 3 |
29 | fev1/pre | 3 |
30 | glucose-load | 1 |
31 | hepatitic | 14 |
32 | histolyticum/perfringens | 1 |
33 | hoc | 2,451 |
34 | hoc-developed | 1 |
35 | holotomographic | 1 |
36 | indepen- | 1 |
37 | index-interview | 1 |
38 | injectionem | 1 |
39 | interventions.subgroup | 1 |
40 | interventioti | 1 |
41 | laparatomies | 1 |
42 | latent-subgroup | 1 |
43 | lipocryolyisis | 3 |
44 | llin-distribution | 1 |
45 | lyric | 3 |
46 | mortem | 61 |
47 | morten | 1 |
48 | multi-array | 3 |
49 | multichip | 2 |
50 | natally | 1 |
51 | natum | 2 |
52 | one-variable-at-a-time | 1 |
53 | op. | 1 |
54 | partum | 272 |
55 | pci-bleeding | 1 |
56 | polt | 1 |
57 | rates.statistical | 1 |
58 | remission-therapy | 1 |
59 | revised-consort | 3 |
60 | segregant | 3 |
61 | splicing-point | 2 |
62 | square-discriminant | 3 |
63 | squares-discriminant | 13 |
64 | squares-discriminate | 6 |
65 | squares-discrimination | 2 |
66 | stereophotogrammetric | 7 |
67 | stroke-onset | 1 |
68 | surrogation | 1 |
69 | third-dose | 1 |
70 | transfusionnal | 1 |
71 | transplant.in | 1 |
72 | treatment-by-tiredness | 1 |
73 | volume-strain | 1 |
1 | indepen- | 1 |
2 | op. | 1 |
3 | 7,670 | 1 |
4 | 237.21 | 1 |
5 | 521.6±83.5 | 1 |
6 | 148.1±34.5 | 1 |
7 | 14,15 | 1 |
8 | 24.7±8.8 | 1 |
9 | 45.1±24.9 | 1 |
10 | 466.9 | 1 |
11 | 48.1±8.9 | 1 |
12 | holotomographic | 1 |
13 | stereophotogrammetric | 7 |
14 | analysis-biometric | 1 |
15 | lyric | 3 |
16 | hepatitic | 14 |
17 | hoc | 2,451 |
18 | glucose-load | 1 |
19 | hoc-developed | 1 |
20 | abcg2-mediated | 1 |
21 | one-variable-at-a-time | 1 |
22 | fev1-pre | 3 |
23 | fev1/pre | 3 |
24 | third-dose | 1 |
25 | squares-discriminate | 6 |
26 | alcohol-negative | 1 |
27 | pci-bleeding | 1 |
28 | deswelling | 1 |
29 | cell-sorting | 3 |
30 | interventioti | 1 |
31 | 0.06-μg/l | 1 |
32 | rates.statistical | 1 |
33 | development.statistical | 1 |
34 | transfusionnal | 1 |
35 | fenestram | 1 |
36 | injectionem | 1 |
37 | mortem | 61 |
38 | cibum | 2 |
39 | natum | 2 |
40 | coitum | 4 |
41 | partum | 272 |
42 | morten | 1 |
43 | transplant.in | 1 |
44 | volume-strain | 1 |
45 | surrogation | 1 |
46 | squares-discrimination | 2 |
47 | llin-distribution | 1 |
48 | multichip | 2 |
49 | latent-subgroup | 1 |
50 | interventions.subgroup | 1 |
51 | laparatomies | 1 |
52 | discharge.this | 1 |
53 | lipocryolyisis | 3 |
54 | histolyticum/perfringens | 1 |
55 | treatment-by-tiredness | 1 |
56 | distribution.cost-effectiveness | 1 |
57 | stroke-onset | 1 |
58 | .onset | 1 |
59 | polt | 1 |
60 | segregant | 3 |
61 | square-discriminant | 3 |
62 | squares-discriminant | 13 |
63 | cfa-treatment | 1 |
64 | splicing-point | 2 |
65 | revised-consort | 3 |
66 | 45/post | 2 |
67 | index-interview | 1 |
68 | multi-array | 3 |
69 | natally | 1 |
70 | 1-only | 2 |
71 | adenoidectomy/tonsillectomy | 1 |
72 | 3-week-therapy | 1 |
73 | remission-therapy | 1 |